Validation of the IPSS-R in lenalidomide-treated, lower-risk myelodysplastic syndrome patients with del(5q)

Detalles Bibliográficos
Autores principales: Sekeres, M A, Swern, A S, Fenaux, P, Greenberg, P L, Sanz, G F, Bennett, J M, Dreyfus, F, List, A F, Li, J S, Sugrue, M M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219467/
https://www.ncbi.nlm.nih.gov/pubmed/25171203
http://dx.doi.org/10.1038/bcj.2014.62

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4219467/
https://www.ncbi.nlm.nih.gov/pubmed/25171203
http://dx.doi.org/10.1038/bcj.2014.62

Ejemplares similares